Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    "Gastroschisis"
Show Display Options
Rank Status Study
1 Recruiting Silo Versus Primary Closure for Gastroschisis
Condition: Gastroschisis
Interventions: Procedure: silo;   Procedure: Primary closure for gastroschisis
2 Recruiting Music Therapy: An Adjunct To Gastroschisis Infants' Care
Condition: Gastroschisis
Intervention:
3 Terminated Bedside Silo Versus Operative Closure for Gastroschisis
Condition: Gastroschisis
Interventions: Procedure: Bedside Silo;   Procedure: Operative attempt at closure
4 Recruiting Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care
Condition: Gastroschisis
Intervention: Other: Early Delivery
5 Completed Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis
Condition: Gastroschisis
Interventions: Procedure: Primary placement of a spring-loaded silo;   Procedure: Primary Closure
6 Recruiting Sutureless vs Sutured Gastroschisis Closure
Condition: Gastroschisis
Intervention: Procedure: Sutureless gastroschisis closure
7 Unknown  Probiotics in Infants With Gastroschisis
Condition: Gastroschisis
Interventions: Dietary Supplement: Bifidobacteria infantis;   Other: Placebo
8 Unknown  Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses
Condition: Gastroschisis
Intervention: Procedure: AMNIOECHANGE
9 Recruiting Metoclopramide Pilot Trial
Condition: Gastroschisis
Interventions: Drug: intravenous metoclopramide;   Other: Placebo
10 Unknown  Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Conditions: Cholestasis;   Prematurity;   Gastroschisis;   Intestinal Atresia;   Necrotizing Enterocolitis
Intervention: Drug: Parenteral Nutrition
11 Suspended Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Conditions: Intestinal Failure;   Short Bowel Syndrome
Interventions: Drug: Glucagon-Like Peptide 2;   Drug: Glucagon like peptide-2

Indicates status has not been verified in more than two years